PKM and colorectal carcinoma: Moreover, Zheng et al. (2020) demonstrated that XIST/miR-137 signals enhanced glycolysis and chemotherapy tolerance of CRC by increasing the PKM2-to-PKM1 ratio, thus providing another option for improving the efficacy of chemotherapy in CRC patients (Fig. 1R).